Simple urine test may spot kidney trouble early in kids with cancer
NCT ID NCT02822404
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a substance called cystatin C, measured in urine and blood, can detect kidney damage from chemotherapy drugs cisplatin and ifosfamide in children. Researchers followed 42 children and compared cystatin C levels to standard kidney tests. The goal was to find a simpler, less burdensome way to monitor kidney health during cancer treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If cystatin C proves reliable, it could offer a simpler, less invasive way to monitor kidney health in children undergoing chemotherapy.
- What could go wrong
- This is a small, completed observational study. The marker may not be accurate enough to replace current tests, and results may not apply to all children or treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Toulouse
Toulouse, 31059, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Contrast dye Double-Dose: new study tracks kidney fallout in ICU patients
- Could a simple breath test spot hidden diseases early?
- Steroids for kidney disease: do they prevent failure Long-Term?
- New drug shows promise for kidney disease patients
- New implant aims to simplify dialysis fistula monitoring
- Dialysis patients wear heart monitors for a week to uncover hidden risks